Spyros I. Siakavellas

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos et al. · Hepatology · 2017 · 292 citations

Medicine, Oncology, Pharmacotherapy +15

Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis

Giorgos Bamias, Spyros I. Siakavellas, Kimon Stamatelopoulos et al. · Clinical Immunology · 2008 · 114 citations

Veterinary Medicine, Clinical Sciences, Immunology +12

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

George Papatheodoridis, Vana Sypsa, George Ν. Dalekos et al. · Journal of Hepatology · 2018 · 109 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Changing Pattern in the Clinical Presentation of Pediatric Celiac Disease: A 30-Year Study

Elefthería Roma, Joanna Panayiotou, Helen Karantana et al. · Digestion · 2009 · 101 citations · Full text

Medicine, Child Health, Pediatrics +14

Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy

Giorgos Bamias, Ioanna Delladetsima, Μarina Perdiki et al. · Cancer Investigation · 2017 · 99 citations

Veterinary Medicine, Immunology, Oncology +17